Aurelia Alexandru - Researcher Profile

Publications

2 shown

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok , Yi‐Long Wu , Iveta Kudaba +97 more

2019 The Lancet 3175 citations

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

Matthew D. Hellmann , Luis Paz‐Ares , Reyes Bernabé +23 more

First-line treatment with nivolumab plus ipilimumab resulted in a longer duration of overall survival than did chemotherapy in patients with NSCLC, independent of the PD-L1 expr...

2019 New England Journal of Medicine 2696 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 5,871
Institution: Institutul Oncologic Bucuresti

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0009-0009-1420-1034

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.